March 10, 2017 / 1:09 PM / 5 months ago

BRIEF-Corvus Pharmaceuticals qtrly loss per share $0.55

1 Min Read

March 10 (Reuters) - Corvus Pharmaceuticals Inc:

* Corvus Pharmaceuticals reports fourth quarter and full year 2016 financial results and provides business update

* Corvus Pharmaceuticals inc qtrly loss per share $0.55

* Corvus Pharmaceuticals inc - sees net cash utilization of $55 million to $60 million in 2017

* Corvus Pharmaceuticals inc - at December 31, 2016, corvus had cash, cash equivalents and marketable securities totaling $134.9 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below